Oncolytics Biotech (ONCY) Tops Q1 Loss Views by 3c
Tweet
Share
E-mailGet Alerts ONCY Hot Sheet
Join SI Premium – FREE
Oncolytics Biotech (NASDAQ: ONCY) reported Q1 loss of ($0.06), $0.03 better than the analyst estimate of ($0.09).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oncolytics Biotech (ONCY) PT Lowered to $5 at H.C. Wainwright
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- J. M. Smucker (SJM) Tops Q1 EPS by 103c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
